Daniel LeSueur is COO at Health Catalyst, Inc. (HCAT). They have made 1 open-market trade across 1 company since 2024, most recently 2025-09-02.
CIK 0002013388
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| HCAT | 198,367 | $343K |
Shares reported on the most recent Form 4, priced at the 2025-09-04 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HCAT | SELL · 10b5-1 | 2025-05-05 | 2025-05-07 | $4.10 | $21K | -19.1% | -14.9% | -20.7% |
| HCAT | SELL · 10b5-1 | 2025-04-03 | 2025-04-07 | $4.15 | $22K | -5.2% | -2.0% | -2.5% |
| HCAT | SELL · 10b5-1 | 2025-03-05 | 2025-03-10 | $4.52 | $153K | +8.0% | +0.2% | +3.7% |
| HCAT | SELL · 10b5-1 | 2025-02-05 | 2025-02-06 | $5.76 | $30K | +0.0% | -28.5% | -28.5% |
| HCAT | SELL · 10b5-1 | 2025-01-06 | 2025-01-10 | $7.51 | $39K | -15.0% | -15.6% | -43.8% |
| HCAT | SELL · 10b5-1 | 2024-12-04 | 2024-12-06 | $7.70 | $351K | -13.9% | -12.3% | -47.5% |
| HCAT | SELL · 10b5-1 | 2024-11-05 | 2024-11-07 | $7.70 | $40K | -14.5% | -5.4% | -33.2% |
| HCAT | SELL · 10b5-1 | 2024-10-03 | 2024-10-08 | $7.68 | $40K | +10.9% | +13.4% | -5.2% |
| HCAT | SELL | 2024-09-04 | 2024-09-05 | $7.58 | $123K | +18.5% | +3.8% | +8.0% |
| HCAT | SELL · 10b5-1 | 2024-08-05 | 2024-08-07 | $6.19 | $32K | +5.2% | +12.2% | +19.4% |
| HCAT | SELL · 10b5-1 | 2024-07-03 | 2024-07-08 | $6.15 | $32K | +12.8% | -10.9% | +23.9% |
| HCAT | SELL · 10b5-1 | 2024-06-06 | 2024-06-12 | $6.72 | $160K | -8.6% | -2.3% | +18.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.